- Neuro-All - University of Manitoba Mailing Lists

Your input is important and appreciated
by Winnipeg Chapter Society for Neuroscience 10 Feb '14

10 Feb '14

Dear Neuroscientists, We have started to plan the Manitoba Neuroscience Network - 2014 Annual Meeting and are again looking into the possibility of holding a Retreat-style meeting mid-end of June, held over 2 days, at a site within two hours drive (e.g. Whiteshell, Kenora etc.) where a stay overnight would be encouraged (to enhance team building!). Our main focus for this year will be to feature new staff's research, with a secondary focus on promoting interests in establishing research teams (ideally linking CIHR pillars 1 and 2). Therefore, we encourage attendance from researchers in the basic and clinical realms. By at least getting pillars 1 and 2 to communicate at some point in the future we could then identify possible staff in pillars 3 and 4 at UofM (or elsewhere). And then we have the basis for competitive team grants with a strong UofM flavor. Could those that would potentially attend a retreat-style meeting in mid-end June, held over 2 days at a site ~2 hrs drive away (e.g. Whiteshell, etc), please respond ASAP so we can start planning. Regards, Paul Paul Fernyhough Program Chair - Manitoba Neuroscience Network 2014 Annual Meeting Director, Division of Neurodegenerative Disorders, St. Boniface Research Centre Professor, Departments of Pharmacology & Therapeutics, Physiology University of Manitoba Kelly Jorundson Winnipeg Chapter Society for Neuroscience R4046 - 351 Tache Avenue Winnipeg, MB R2H 2A6 Tel: 204.235.3939 Fax: 204.237.4092 Email: kjorund(a)sbrc.ca OR kjorund(a)yahoo.ca Website: www.sfn-manitoba.ca

1 0

upcoming seminars
by Winnipeg Chapter Society for Neuroscience 04 Feb '14

04 Feb '14

Everyone is invited to attend! Manitoba Neuroscience Network Seminar Series Friday, February 28th, 2014 9:00 am PX236/238 PsychHealth Bldg. Dr. V. Wee Yong <http://www.ucalgary.ca/dcns/experimental/members/Yong> Professor, Canada Research Chair in Nueroimmunology Hotchkiss Brain Institute and Department of Clinical Neurosciences and Oncology University of Calgary Topic: Overcoming inhibitors in the lesion microenvironment for CNS regeneration. Biosketch: Dr. V. Wee Yong is a Professor at the Hotchkiss Brain Institute and the Departments of Clinical Neurosciences and Oncology at The University of Calgary. He co-directs the Multiple Sclerosis (MS) Program of the Hotchkiss Brain Institute, providing the basic science leadership, and he holds the Canada Research Chair in Neuroimmunology. Dr. Yong received his Ph.D. from the University of British Columbia, Vancouver, and started his faculty appointment at the Montreal Neurological Institute, McGill University, in 1989. He located to Calgary in 1996. Dr. Yong's research interests lie in the area of neuroimmunology, neuroprotection and CNS regeneration, and his projects have been guided by MS, spinal cord injury and malignant gliomas. Dr. Yong has published 230 peer-reviewed manuscripts and his research has been translated into clinical trials in MS and spinal cord injury. His work has been cited over 12,000 times by other authors in scientific publications. In 2003, Dr. Yong was awarded the Queen's Golden Jubilee Year Medallion for volunteer activities on behalf of the MS Society of Canada. In 2010, Dr. Yong was elected a fellow of the Canadian Academy of Health Sciences, a top honor for those working in the medical sciences. Dr. Yong is the immediate past chair of the Medical Advisory Committee of the MS Society of Canada, he directs the Alberta endMS Regional Research and Training Center, and he is on the editorial board of 7 international journals. In 2012, Dr. Yong was elected by an international community to be the Vice President of the International Society of Neuroimmunology; he will become its President in 2014. Brief description of research interests: Neuroimmunology is the study of inflammation in the nervous system. Virtually all neurological disorders have inflammatory components, and these include diseases traditionally associated with overt inflammation, such as multiple sclerosis (MS), and those previously thought to be purely degenerative, including Alzheimer's disease. Neuroinflammation originates from the trafficking of several leukocyte subsets into the nervous system and through the production of immune molecules by neural cells themselves. The interaction between leukocytes and neural cells further promotes neuroinflammation and injury. In recent years, reparative properties of neuroinflammation have been appreciated, so that the balance between beneficial and detrimental neuroinflammation is a crucial determinant of outcome. My research projects have been guided by 3 diseases of the central nervous system (CNS): MS, spinal cord injury (SCI) and brain tumors (malignant gliomas). MS and SCI provide my research program with diseases of chronic and acute neuroinflammation, respectively. In contrast, malignant gliomas present a disease of immunosuppression, whereby the cancer cells neutralize the activity of leukocytes that infiltrate into these tumors. My research has been translated into clinical trials in MS and in spinal cord injury. Collectively, my studies of neuroimmunology are aimed at understanding, controlling and tipping the balance of neuroinflammation towards one of neuroprotection and regeneration from CNS insults. Presented in co-operation with University of Manitoba Clinical Neuroscience Rounds ************************************** Division of Neurodegenerative Disorders, St. Boniface Hospital Research Neuroscience Seminar Series Friday, February 28th2014 12:00 Noon 500 John Buhler Research Centre - Bannatyne Campus Dr. Bruce Perkins <http://www.uhnresearch.ca/researchers/profile.php?lookup=7067> Associate Professor, Division of Endocrinology and Metabolism University of Toronto & Clinician Scientist, Lunenfeld Tanenbaum Research Institute, Leadership Sinai Centre for Diabetes, Mount Sinai Hospital Topic: The Identification of Diabetic Neuropathy in type 1 Diabetes Biosketch: Bruce A Perkins, MD MPH is Associate Professor and Endocrinologist at the University of Toronto, and a Diabetes Complications Clinician-Scientist. He obtained his MD and Internal Medicine training at the University of Toronto, his endocrinology subspecialty training at Harvard University, his Masters of Public Health in Epidemiology at the Harvard School of Public Health, and a research fellowship in epidemiology at the Joslin Diabetes Center. In 2003 he was appointed at the Toronto General Hospital and earned a Canadian Diabetes Association early career personnel award for his work in diabetic neuropathy. His clinical practice has focused on type 1 diabetes management, and he directed the formation of an insulin pump program at the UHN. His research work has focused on clinical biomarkers for the early stages of diabetes complications using longitudinal cohort methods as well as clinical trials. Highlights are "Early GFR Loss" as a predictive marker for risk of advanced kidney disease using serial cystatin C analysis and the concept of in-vivo Corneal Confocal Microscopy as a method to analyze the small fiber morphological abnormalities that predict diabetic neuropathy. His clinical trial work in insulin pump and continuous glucose monitoring interventions has contributed to refinements in type 1 diabetes care. He is active on national and international diabetes clinical practice guideline committees including Microvascular Chair on the CDA's 2013 Clinical Practice Guidelines Steering Committee. He has received funding from the Juvenile Diabetes Research Foundation, Canadian Diabetes Association, CIHR, and the Banting and Best Diabetes Center and is a member of the JDRF's Canadian Clinical Trial Network. He is initiating a JDRF-funded nation-wide cohort study to determine factors associated with longevity in type 1 diabetes. Presented in co-operation with Manitoba Institute of Child Health Kelly Jorundson Administrative Manager, Division of Neurodegenerative Disorders St. Boniface Hospital Research & Department of Pharmacology & Therapeutics University of Manitoba Room R4046 - 351 Taché Avenue Winnipeg, MB R2H 2A6 CANADA Tel: 204.235.3939 Fax: 204.237.4092 Email: kjorund(a)sbrc.ca OR kjorund(a)yahoo.ca Website: www.sbrc.ca/dnd OR www.umanitoba.ca/medicine/units/pharmacology

1 0

Reminder - MNN Seminar Friday @ 9am - Soheila Karimi
by Winnipeg Chapter Society for Neuroscience 29 Jan '14

29 Jan '14

Everyone is invited.. Manitoba Neuroscience Network Seminar Friday, January 31st, 2014 | 9:00 am Seminar Series Dr. Soheila Karimi Assistant Professor in Physiology and Biochemistry & Medical Genetics Senior Scientist, Regenerative Medicine Program Principal Investigator, Spinal Cord Research Center Scientist, Manitoba Institute of Child Health Faculty of Medicine, University of Manitoba Topic: Spinal Cord Injury: Elucidating Injury Mechanisms and Developing Repair Strategies Location: PX236/238 PsychHealth Bldg. Biosketch: Dr. Karimi received her PhD degree in Neurosciences from the University of Saskatchewan in 2001. She then undertook a Postdoctoral Fellowship in Spinal Cord Injury and Stem Cell Research at the Toronto Western Research Institute. Dr. Karimi has had a long-term interest in spinal cord regeneration with a special focus on the application of neural stem cells for the treatment of spinal cord injury (SCI). During her training, she received a number of academic and research awards including postdoctoral fellowships from the CIHR, Ontario Neurotrauma Foundation and the Heart and Stroke Foundation. Her postdoctoral work broke a new ground in SCI therapeutic field by showing that transplantation of adult neural stem cells can be used therapeutically to replace lost oligodendrocytes and functionally restore the damaged myelin sheath around the injured axons with improved recovery of function. In 2006, she received the prestigious Synthes Award from the American Association of Neurological Surgeons for this work. Prior to joining the University of Manitoba in 2010, Dr. Karimi was an adjunct Assistant Professor at the University of Toronto from 2007 to 2009. Research Interests: Current research in Karimi's laboratory has focused on regenerative medicine strategies to therapeutically optimize the regenerative potential of resident and transplanted neural stem cells for SCI repair. Adult neural stem cells hold tremendous promise for the repair of injured spinal cord since they have multipotential abilities to replace all damaged neural cells and the potential to provide a supporting environment for repair and regeneration. Using pre-clinical models of SCI, Karimi's team strives to understand how the properties NSCs are modulated within the post-SCI niche. The goal is to recruit NSCs efficiently to replace damaged oligodendrocytes and promote axon remyelination and functional recovery. The team has recently discovered key factors that seem to play major roles in regulating the proliferation and differentiation of neural stem cells in SCI condition. Elucidating the underlying mechanisms of stem cell functions will aid in identifying potential therapeutic targets for enhancing cell replacement and tissue reconstruction after SCI. Dr. Karimi's research has been supported by national, international and local grants from CFI, NSERC, Christopher and Dana Reeve Foundation, Craig Neilsen Foundation, MHRC, Canadian Paraplegic Association, HSC Foundation, MICH, MMSF, Thorlakson Foundation, and U of M. Kelly Jorundson Administrative Manager, Division of Neurodegenerative Disorders St. Boniface Hospital Research & Department of Pharmacology & Therapeutics University of Manitoba Room R4046 - 351 Taché Avenue Winnipeg, MB R2H 2A6 CANADA Tel: 204.235.3939 Fax: 204.237.4092 Email: kjorund(a)sbrc.ca OR kjorund(a)yahoo.ca Website: www.sbrc.ca/dnd OR www.umanitoba.ca/medicine/units/pharmacology

1 0

Physiology/SCRC Candidate Lecture, Dr. Katinka Stecina, January 16, 2014
by Winnipeg Chapter Society for Neuroscience 13 Jan '14

13 Jan '14

Everyone is invited. DEPARTMENT OF PHYSIOLOGY & PATHOPHYSIOLOGY SPINAL CORD RESEARCH CANDIDATE Katinka Stecina, PhD Copenhagen University Department of Neuroscience and Pharmacology "Connecting Mice and Man: Spinal Neuronal Circuits in Sensory-Motor Integration" Thursday, January 16, 2014 10:00 - 11:00 am Theatre C Bannatyne Campus Everyone welcome Contact information: Physiology(a)umanitoba.ca or (204) 789-3696 Judith A Olfert Department of Physiology & Pathophysiology 432 Basic Medical Sciences Building Tel: 204-789-3696 | Fax: 204-789-3934 email: Judith.Olfert(a)med.umanitoba.ca Department of Physiology & Pathophysiology website <http://umanitoba.ca/faculties/medicine/units/physiology/> Kelly Jorundson Winnipeg Chapter Society for Neuroscience R4046 - 351 Tache Avenue Winnipeg, MB R2H 2A6 Tel: 204.235.3939 Fax: 204.237.4092 Email: kjorund(a)sbrc.ca OR kjorund(a)yahoo.ca Website: www.sfn-manitoba.ca

1 0

Manitoba Neuroscience Network Seminar - Dr. Soheila Karimi - Friday Jan 31st 9am
by Winnipeg Chapter Society for Neuroscience 08 Jan '14

08 Jan '14

Manitoba Neuroscience Network Seminar Friday, January 31st, 2014 | 9:00 am Seminar Series Dr. Soheila Karimi Assistant Professor in Physiology and Biochemistry & Medical Genetics Senior Scientist, Regenerative Medicine Program Principal Investigator, Spinal Cord Research Center Scientist, Manitoba Institute of Child Health Faculty of Medicine, University of Manitoba Topic: Spinal Cord Injury: Elucidating Injury Mechanisms and Developing Repair Strategies Location: PX236/238 PsychHealth Bldg. Biosketch: Dr. Karimi received her PhD degree in Neurosciences from the University of Saskatchewan in 2001. She then undertook a Postdoctoral Fellowship in Spinal Cord Injury and Stem Cell Research at the Toronto Western Research Institute. Dr. Karimi has had a long-term interest in spinal cord regeneration with a special focus on the application of neural stem cells for the treatment of spinal cord injury (SCI). During her training, she received a number of academic and research awards including postdoctoral fellowships from the CIHR, Ontario Neurotrauma Foundation and the Heart and Stroke Foundation. Her postdoctoral work broke a new ground in SCI therapeutic field by showing that transplantation of adult neural stem cells can be used therapeutically to replace lost oligodendrocytes and functionally restore the damaged myelin sheath around the injured axons with improved recovery of function. In 2006, she received the prestigious Synthes Award from the American Association of Neurological Surgeons for this work. Prior to joining the University of Manitoba in 2010, Dr. Karimi was an adjunct Assistant Professor at the University of Toronto from 2007 to 2009. Research Interests: Current research in Karimi's laboratory has focused on regenerative medicine strategies to therapeutically optimize the regenerative potential of resident and transplanted neural stem cells for SCI repair. Adult neural stem cells hold tremendous promise for the repair of injured spinal cord since they have multipotential abilities to replace all damaged neural cells and the potential to provide a supporting environment for repair and regeneration. Using pre-clinical models of SCI, Karimi's team strives to understand how the properties NSCs are modulated within the post-SCI niche. The goal is to recruit NSCs efficiently to replace damaged oligodendrocytes and promote axon remyelination and functional recovery. The team has recently discovered key factors that seem to play major roles in regulating the proliferation and differentiation of neural stem cells in SCI condition. Elucidating the underlying mechanisms of stem cell functions will aid in identifying potential therapeutic targets for enhancing cell replacement and tissue reconstruction after SCI. Dr. Karimi's research has been supported by national, international and local grants from CFI, NSERC, Christopher and Dana Reeve Foundation, Craig Neilsen Foundation, MHRC, Canadian Paraplegic Association, HSC Foundation, MICH, MMSF, Thorlakson Foundation, and U of M. Kelly Jorundson Winnipeg Chapter Society for Neuroscience R4046 - 351 Tache Avenue Winnipeg, MB R2H 2A6 Tel: 204.235.3939 Fax: 204.237.4092 Email: kjorund(a)sbrc.ca OR kjorund(a)yahoo.ca Website: www.sfn-manitoba.ca

1 0

Outreach Opportunity
by Winnipeg Chapter Society for Neuroscience 06 Jan '14

06 Jan '14

Dear Neuroscientists and Winnipeg SFN Members: Happy New Year to all of you. One of the primary mandates of the Winnipeg Society for Neuroscience Chapter is community outreach. The Chapter is always looking for ways to share knowledge and opportunities. One way to do this is to provide expert public lectures or discussion opportunities to interested parties. I recently linked with the Human Resources Department of Standard Aero - a major aerospace industry employer in Winnipeg. They would very much like to arrange a neuroscience talk or discussion session with their employees. The topic and format are flexible and are ready to be shaped by a willing volunteer or volunteers. I would very much like to arrange something for them and possibly later for others in a similar manner. If there is anyone who would like to serve the discipline and community in this way, please contact us at wcsn(a)sbrc.ca. Chris Anderson President, Winnipeg Chapter Society for Neuroscience Kelly Jorundson Winnipeg Chapter Society for Neuroscience R4046 - 351 Tache Avenue Winnipeg, MB R2H 2A6 Tel: 204.235.3939 Fax: 204.237.4092 Email: kjorund(a)sbrc.ca OR kjorund(a)yahoo.ca Website: www.sfn-manitoba.ca

1 0

High-risk, high-reward translation neuroscience grant opportunity
by Kelly Jorundson 11 Dec '13

11 Dec '13

[http://www.ccconserv.org/images/logo-weston.png] Neuroscience Funding Opportunity The W. Garfield Weston Foundation is running the 2013 Rapid Response request for applications in neuroscience research this winter. Deadline - January 7, 2014 at 11:00 a.m. ET * Goal: to support novel, high-risk, high-reward translational research that will accelerate the development of therapeutics for neurodegenerative diseases of aging. * Grant size: up to $150,000 per project over 12-18 months, to a maximum of $4.5 million across all projects. * Eligibility: researchers at or above the level of postdoctoral fellow or equivalent from registered charitable institutions in Canada. Applicants with high potential Letters of Intent will be invited to submit a short proposal. Awards will be announced in late spring. Please contact us with any questions about this RFA at neuro(a)weston.ca<mailto:neuro@weston.ca> or (416) 935-4056. Apply Here<https://weston.smartsimple.ca/welcome/neuroscience> || More Information<http://www.westonfoundation.org/Pages/neurorapid.aspx> This email message is confidential, may be legally privileged and is intended for the exclusive use of the addressee. If you received this message in error or are not the intended recipient, you should destroy the email message and any attachments or copies, and you are prohibited from retaining, distributing, disclosing or using any information contained. Please inform us of the delivery error by return email. Thank you for your cooperation. Le présent message électronique est confidentiel et peut être couvert par le secret professionnel. Il est à l'usage exclusif du destinataire. Si vous recevez ce message par erreur ou si vous n'en êtes pas le destinataire prévu, vous devez détruire le message et toute pièce jointe ou copie et vous êtes tenu de ne pas conserver, distribuer, divulguer ni utiliser tout renseignement qu'il contient. Veuillez nous informer de toute erreur d'envoi en répondant à ce message. Merci de votre collaboration. Kelly Jorundson Executive Assistant Winnipeg Chapter Society for Neuroscience R4046 - 351 Tache Avenue Winnipeg, MB R2H 2A6 Tel: 204.235.3939 Fax: 204.237.4092 Email: kjorund(a)sbrc.ca OR Kelly.jorundson(a)med.umanitoba.ca<mailto:Kelly.jorundson@med.umanitoba.ca> Website: www.sfn-manitoba.ca<http://www.sfn-manitoba.ca>

1 0

Invitation to join - Manitoba Multiple Sclerosis Research Network
by Kelly Jorundson 06 Dec '13

06 Dec '13

-------------------------------------- Sent on behalf of Dr. Mike Namaka Dear all, The purpose of this email is to inform you that Dr. Karen Ethans and myself (Dr. Mike Namaka) have recently founded a specialized research interest group called the "Manitoba Multiple Sclerosis Research Network". This research network organization is a non-profit organization that has a specific focus on the disease Multiple Sclerosis (MS). This organization was charged with the responsibility of identifying all MS specialists and people with an inherent interest in advancing our knowledge in the field of MS. The organization has drafted a preliminary outline identifying the core objectives of this special interest group which are as follows: Preliminary - Draft of Objectives for this Special Interest Group * To identify those individuals in Manitoba with a specialized expertise or interest in multiple sclerosis (MS). * To foster research collaboration amongst those individuals in Manitoba with a specialized expertise in MS. * To facilitate knowledge transfer and dissemination amongst the identified areas of areas of MS expertise through cross training of undergraduate, graduate and medical students. * To apply the knowledge transfer obtained amongst the MS sub-specialties through the joint submission to peer-reviewed granting agencies (CIHR, MS Society) that lead to the publication of high impact peer-reviewed publications. * To establish a stronger presence of MS research in Manitoba that will lead to increased participation of the MS specialists of Manitoba in the National endMS program. We are requesting your assistance in the distribution of this letter throughout your research units to assist us in identifying those individuals involved in MS research in Manitoba. We would like to extend an invitation to those individuals to join our organization free of charge. The organization meets quarterly and the next meeting will be held in the later part of December with a subsequent meeting held in March 2014. Please email the program coordinator Claudia Cortes at claudiacortesp(a)gmail.com<mailto:claudiacortesp@gmail.com> asap to ensure your name and email are added to the membership list. Thanks very much for your consideration of this request. I look forward to your reply at your earliest convenience. Sincerely, Dr. Mike Namaka Kelly Jorundson Executive Assistant Winnipeg Chapter Society for Neuroscience R4046 - 351 Tache Avenue Winnipeg, MB R2H 2A6 Tel: 204.235.3939 Fax: 204.237.4092 Email: kjorund(a)sbrc.ca<mailto:kjorund@sbrc.ca> OR Kelly.jorundson(a)med.umanitoba.ca<mailto:Kelly.jorundson@med.umanitoba.ca> Website: www.sfn-manitoba.ca<http://www.sfn-manitoba.ca>

1 0

MNN Visiting Speaker - Dr. Philippe Seguela
by Kelly Jorundson 28 Nov '13

28 Nov '13

Neuroscience Network Seminar: Dr. P. Seguela, Nov. 29, 2013 The Winnipeg Chapter Society for Neuroscience is pleased to announce this upcoming Manitoba Neuroscience Network Seminar<http://www.sfn-manitoba.ca/news/?id+20130919wcsn.txt>... [http://www.mni.mcgill.ca/files/neuro_team/philippe-seguela.jpg] Date: Friday, November 29, 2013 Time: 12:00 noon - 1:00 pm Location: Theatre C, BMSB, Bannatyne Campus Dr. Philippe Seguela Professor, Montreal Neurological Institute Alan Edwards Centre for Research on Pain Department of Neurology and Neurosurgery McGill University Topic: Optogenetic control of pain pathways For more information, contact the MNN Office at (T) 235.3939 or email: mnn(a)sbrc.ca<mailto:mnn@sbrc.ca> Presented in co-operation with University of Manitoba Clinical Neuroscience Rounds An initiative of the Winnipeg Chapter Society for Neuroscience Kelly Jorundson Administrative Manager Neuroscience Research Program Kleysen Institute for Advanced Medicine Faculty of Medicine University of Manitoba Executive Assistant Winnipeg Chapter Society for Neuroscience & Manitoba Neuroscience Network SR452 - 710 William Avenue Winnipeg, MB R3E 0Z3 Tel: 204.318.2569 Email: kelly.jorundson(a)med.umanitoba.ca<mailto:kelly.jorundson@med.umanitoba.ca> OR kjorund(a)yahoo.ca<mailto:kjorund@yahoo.ca>

1 0

RE: Visiting Speaker Dr. Edward Fon Monday Dec 2-3, 2013
by Kelly Jorundson 28 Nov '13

28 Nov '13

Apologies...name correction Dr. *Edward Fon Dear neuro-all: Dr. Edward Fon is the Department of Pharmacology & Therapeutics guest speaker on the Edge of Science Seminar. He will be presenting on December 2, 2013 (see below) . If you are interested in meeting with Dr. Fon, please contact Raquel Nowlin at 204.789.3520 or email Raquel.Nowlin(a)med.umanitoba.ca<mailto:Raquel.Nowlin@med.umanitoba.ca> asap. REMINDER: Everyone is invited! Edge of Science and Medicine Seminar Series: Date: Monday, December 2, 2013 Time: 12:00 noon Location: Theatre C Basic Medical Sciences Edward A Fon Edward A. Fon, MD, FRCP(C) Director, McGill Parkinson Program And NPF Center of Excellence, FRQS Chercheur-National Associate Director, Clinical & Translational Research Montreal Neurological Institute Associate Professor - McGill University TOPIC: Function of Parkin and PINK1 in Mitochondrial Quality-Control /sent on behalf of Chris Anderson Kelly Jorundson Administrative Manager Neuroscience Research Program Kleysen Institute for Advanced Medicine Faculty of Medicine University of Manitoba Executive Assistant Winnipeg Chapter Society for Neuroscience & Manitoba Neuroscience Network SR452 - 710 William Avenue Winnipeg, MB R3E 0Z3 Tel: 204.318.2569 Email: kelly.jorundson(a)med.umanitoba.ca<mailto:kelly.jorundson@med.umanitoba.ca> OR kjorund(a)yahoo.ca<mailto:kjorund@yahoo.ca>

1 0